Immunogenicity and Safety of Verorab in Indian Population.

Trial Profile

Immunogenicity and Safety of Verorab in Indian Population.

Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2014

At a glance

  • Drugs Rabies vaccine (Primary) ; Rabies vaccine (Primary)
  • Indications Rabies
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 02 Mar 2010 Actual end date (Oct 2008) added as reported by
    • 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by
    • 02 Apr 2008 The expected completion date for this trial is now Apr 2008 according to
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top